6 Dimensions Capital

Portfolio Co Investors 2026 for 6 Dimensions Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

6 Dimensions Capital accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.2B. The median disclosed raise is $108M, and the largest is Fog Pharmaceuticals at $506M, ahead of Brii Biosciences ($260M) and ITeos Therapeutics ($205M).

The names that recur most often on these co-invested cap tables are 6 Dimensions Capital (14 companies), GV (3 companies), Blue Pool Capital (2 companies), RA Capital Management (2 companies), Invus (2 companies), Canaan Partners (2 companies). By latest disclosed round, the market skews Series B (6), Series A (4), Series E (1), Series C (1).

Best funded 6 Dimensions Capital companies

  1. Fog Pharmaceuticals — $506M (latest: Series E)
  2. Brii Biosciences — $260M (latest: Series A)
  3. ITeos Therapeutics — $205M (latest: Series B)
  4. Halda Therapeutics — $202M (latest: Series B)
  5. Ignis Therapeutics — $185M (latest: Series A)
  6. TScan Therapeutics — $180M (latest: Series C)
  7. Centrexion Therapeutics — $108M (latest: Growth)
  8. Exo Therapeutics — $103M (latest: Series B)
  9. Nanos Medical — $100M (latest: Series D)
  10. C Ray Therapeutics — $100M (latest: Series A)
  11. IDEAYA Biosciences — $94M (latest: Series B)
  12. Engine Biosciences — $94M (latest: Series A)
  13. AnchorDx — $83M (latest: Series B)
  14. Lyvgen Biopharma — $30M (latest: Series B)

6 Dimensions Capital — related firms and companies (56)

6 Dimensions Capital profile · All research reports